Fred Parietti, Multiply Labs CEO on Robotics and Biomanufacturing

Fred Parietti is the CEO and co-founder of Multiply Labs, a robotics company developing automated manufacturing systems for individualized medicines, including cell therapies. ~~~~~~~~~~~~~This episode is brought to you by Nebius — the ultimate cloud for AI innovators.Nebius provides AI infrastructure you can count on, combining reliability and speed with flexibility and engineering support unmatched by hyperscalers.AI leaders like Meta, Shopify, and Higgsfield already partner with Nebius to run their AI workloads. Plus, venture-backed startups can save up to $150,000 on compute costs when they apply for access. Visit nebius.com or nebius.com/startups to learn more~~~~~~~~~~~~~Since co-founding the company in 2016, he has raised more than $25 million from investors including Casdin Capital, Lux Capital, Founders Fund, and Fifty Years. Multiply Labs has developed GMP-compliant robotic manufacturing technology for individualized pharmaceuticals and is building robotic systems designed to work with existing GMP instruments used in cell therapy production, helping manufacturers automate processes without significantly changing established protocols. Fred leads a team of more than 35 robotic engineers, pharmaceutical scientists, and FDA experts. He holds a PhD in Mechanical Engineering from MIT, where his research focused on advanced robotic systems and earned the Mechanical Engineering De Florez Design Award. His work spans more than 30 peer-reviewed robotics publications and 12+ patents and patent applications, with over 2,000 citations.Topics

• How robotics can scale the manufacturing of individualized medicines and cell therapies
• Automating cell therapy production while working within existing GMP processes and regulatory requirements
• Building a robotics company at the intersection of advanced engineering, pharmaceutical manufacturing, and patient access

#Robotics #Biotechnology #CellTherapy #PharmaManufacturing #HealthcareAI